. Author manuscript; available in PMC: 2017 Aug 30.

Published in final edited form as: Mod Pathol. 2016 Jul 29;29(11):1306–1312. doi: 10.1038/modpathol.2016.136

Table 1.

Peripheral T-cell lymphomas immunostaining pattern

T-cell lymphoma subtype	No. (%)
T-cell lymphoma subtype	Cyclin D1	Cyclin D2	Cyclin D3	pStat3
Anaplastic large cell lymphoma, ALK+	8/34 (24%)	10/12 (83%)	12/12 (100%)	13/13 (100%)
Anaplastic large cell lymphoma, ALK-	3/44 (7%)	7/15 (47%)	5/15 (33%)	6/16 (38%)
Peripheral T-cell lymphoma, NOS	3/68 (4%)
Angioimmunoblastic T-cell lymphoma	0/24 (0%)
Extranodal NK/T-cell lymphoma, nasal type	0/7 (0%)
Enteropathy associated T-cell lymphoma	0/4 (0%)
Hepatosplenic T-cell lymphoma	0/3 (0%)
Cutaneous anaplastic large cell lymphoma	0/5 (0%)
Mycosis fungoides	0/5 (0%)
Subcutaneous panniculitis-like T-cell lymphoma	0/1 (0%)
CD4-positive pleomorphic T-cell lymphoma	0/1 (0%)
T-cell large granular lymphocytic leukemia	0/4 (0%)
Overall	14/200 (7%)

p value between ALCL, ALK+ and ALCL, ALK-negative for cyclin D1 (p=0.05), cyclin D2 (p=0.28), cyclin D3 (p=0.03), and pSTAT3 (p=0.039)